UK markets closed

Syndax Pharmaceuticals, Inc. (SNDX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
21.06+0.49 (+2.38%)
At close: 04:00PM EDT
21.06 0.00 (0.00%)
After hours: 05:32PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts10101111
Avg. Estimate-0.99-1.04-3.86-2.9
Low estimate-1.11-1.21-4.85-3.74
High estimate-0.91-0.95-3.24-1.06
Year ago EPS-0.59-0.64-2.98-3.86
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts771111
Avg. EstimateN/AN/A29.47M129.01M
Low estimateN/AN/A5.98M71.05M
High estimateN/AN/A81M278.08M
Year ago salesN/AN/AN/A29.47M
Sales growth (year/est)N/AN/AN/A337.80%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-0.6-0.73-0.79-0.99
Actual EPS-0.59-0.64-0.73-1
Difference0.010.090.06-0.01
Surprise %1.70%12.30%7.60%-1.00%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-0.99-1.04-3.86-2.9
7 days ago-0.99-1.04-3.86-2.9
30 days ago-0.99-1.04-3.86-2.9
60 days ago-0.85-0.88-3.18-2.43
90 days ago-0.85-0.88-3.19-2.43
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesSNDXIndustrySector(s)S&P 500
Current qtr.-67.80%N/AN/AN/A
Next qtr.-62.50%N/AN/AN/A
Current year-29.50%N/AN/AN/A
Next year24.90%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A